Search Results - Stephan Spahn

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Unveiling Clinical Relevance: Investigating Placentas Submitted for Histological Examination and Their Correlation with Clinical Indications and Histological Findings by Luisa Strahler, Alexander Horky, Stephan Spahn, Franz Bahlmann, Elise Gradhand

    Published in Life (2024-07-01)
    Get full text
    Article


  2. 2

    Case Report: FGFR2 inhibitor resistance via PIK3CA and CDKN2A/B in an intrahepatic cholangiocarcinoma patient with FGFR2-SH3GLB1 fusion by Nadja Ballin, Alexander Ott, Olga Seibel-Kelemen, Irina Bonzheim, Dominik Nann, Janina Beha, Stephan Spahn, Stephan Singer, Stephan Ossowski, Cristiana Roggia, Christopher Schroeder, Michael Bitzer, Michael Bitzer, Sorin Armeanu-Ebinger

    Published in Frontiers in Oncology (2025-04-01)
    Get full text
    Article


  3. 3

    The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma by Stephan Spahn, Fabian Kleinhenz, Ekaterina Shevchenko, Aaron Stahl, Yvonne Rasen, Christine Geisler, Kristina Ruhm, Marion Klaumuenzer, Thales Kronenberger, Stefan A. Laufer, Holly Sundberg-Malek, Khac Cuong Bui, Marius Horger, Saskia Biskup, Klaus Schulze-Osthoff, Markus Templin, Nisar P. Malek, Antti Poso, Michael Bitzer

    Published in Nature Communications (2024-02-01)
    Get full text
    Article


  4. 4

    Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinoma by Michael Bitzer, Stephan Spahn, Sepideh Babaei, Marius Horger, Stephan Singer, Klaus Schulze-Osthoff, Pavlos Missios, Sergios Gatidis, Dominik Nann, Sven Mattern, Veit Scheble, Konstantin Nikolaou, Sorin Armeanu-Ebinger, Martin Schulze, Christopher Schroeder, Saskia Biskup, Janina Beha, Manfred Claassen, Kristina Ruhm, Antti Poso, Nisar P. Malek

    Published in npj Precision Oncology (2021-09-01)
    Get full text
    Article


Search Tools: